|
Market Cap (22-Jun) $292,012,800 (943rd) |
Close (30-Jun) $0.350 |
Volume (30-Jun) 313,271 |
Shortsold (6-Jun) 238,849 (0.10%) (425th) |
|
52w High $1.79 |
52w Low $0.350 |
P/E - |
EPS -0.02 |
OCC released this announcement to the ASX on 19 April 2023, 13:32. The announcement is not marked as price sensitive, and is 2 page(s) in length and 147.23kb in size.
You can view all announcements from OCC and see how they appear on a price chart on the announcements page.
At the date of this announcement, OCC was 0.063% short sold according to ASIC data. It was ranked the 498th most shorted stock on the ASX. It is now ranked as the 425th most shorted stock on the ASX with 0.099% of total shares short sold as of the latest reported data (06 June 2025).
| Other Recent Announcements from OCC | |
|---|---|
| Orthocell receives A$3.17m R&D tax incentive refund | 21 June 2023, 9:00 |
| Change of Director's Interest Notice - Paul Anderson | 16 June 2023, 9:08 |
| Change of Director's Interest Notice - Paul Anderson | 13 June 2023, 9:25 |
| Cleansing Notice | 19 April 2023, 13:32 |
| Application for quotation of securities - OCC | 19 April 2023, 13:22 |
| Notification regarding unquoted securities - OCC | 19 April 2023, 13:22 |
| Orthocell commences nerve repair study | 18 April 2023, 9:00 |
You must be logged in to post a reply.
Orthocell 